{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:36:46Z","timestamp":1793363806295,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ygyno.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T13:34:56Z","timestamp":1693488896000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Telehealth utilization in gynecologic oncology clinical trials"],"prefix":"10.1016","volume":"177","author":[{"given":"Leslie","family":"Andriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McMinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael C.","family":"Koelper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Chittams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Simpkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ygyno.2023.08.011_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/OP.21.00438","article-title":"Telehealth in oncology: ASCO standards and practice recommendations","volume":"17","author":"Zon","year":"2021","journal-title":"JCO Oncol. Pract."},{"issue":"1","key":"10.1016\/j.ygyno.2023.08.011_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2020.04.694","article-title":"Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis","volume":"158","author":"Pothuri","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.08.011_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/OP.21.00524","article-title":"Taking tele behind the scenes: remote clinical trial monitoring comes of age during the COVID-19 pandemic","volume":"17","author":"Williams","year":"2021","journal-title":"JCO Oncol. Pract."},{"issue":"11","key":"10.1016\/j.ygyno.2023.08.011_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jnci\/djaa144","article-title":"The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute","volume":"113","author":"Tolaney","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2023.08.011_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccell.2020.06.018","article-title":"Digitalized adaptation of oncology trials during and after COVID-19","volume":"38","author":"Li","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ygyno.2023.08.011_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/COC.0000000000000783","article-title":"Clinical trials before, during, and after COVID-19 pandemic","volume":"44","author":"AlSaleh","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.08.011_bb0035","first-page":"568","article-title":"Rethinking cancer clinical trials for COVID-19 and beyond","volume":"1","author":"Doherty","year":"2020","journal-title":"Nat. Can."},{"issue":"7","key":"10.1016\/j.ygyno.2023.08.011_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/1357633X20950180","article-title":"Exploring Australian regional cancer patients\u2019 experiences of clinical trial participation via telehealth","volume":"28","author":"Lee","year":"2022","journal-title":"J. Telemed. Telecare"},{"issue":"2","key":"10.1016\/j.ygyno.2023.08.011_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.20.02953","article-title":"American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care","volume":"39","author":"Pennell","year":"2021","journal-title":"J. Clin. Oncol: Offi. J. American Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.08.011_bb0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/GO.20.00247","article-title":"Single-institution experience in clinical trials during the COVID-19 pandemic in Spain: not so bad after all?","volume":"6","author":"Rodriguez-Otero","year":"2020","journal-title":"JCO Glob. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.08.011_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/07357907.2020.1858311","article-title":"Impact of COVID-19 outbreak through telemedicine implementation on data reporting during oncology clinical trials","volume":"39","author":"Bouleftour","year":"2021","journal-title":"Cancer Investig."},{"issue":"17","key":"10.1016\/j.ygyno.2023.08.011_bb0060","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1002\/cam4.3292","article-title":"COVID-19 pandemic and impact on cancer clinical trials: an academic medical center perspective","volume":"9","author":"Marcum","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.08.011_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygyno.2015.04.025","article-title":"Geographic access to gynecologic cancer care in the United States","volume":"138","author":"Shalowitz","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.08.011_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ogc.2020.02.003","article-title":"Telemedicine and gynecologic cancer care","volume":"47","author":"Shalowitz","year":"2020","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ygyno.2023.08.011_bb0075","series-title":"American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting","first-page":"105","article-title":"Overcoming Barriers to Clinical Trial Enrollment","volume":"39","author":"Nipp","year":"2019"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:05:32Z","timestamp":1758773132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823014403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":15,"alternative-id":["S0090825823014403"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.08.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telehealth utilization in gynecologic oncology clinical trials","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}